Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
M Omata, AL Cheng, N Kokudo, M Kudo, JM Lee… - Hepatology …, 2017 - Springer
There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …
[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association - Korean Journal of Radiology, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
[HTML][HTML] Role of transarterial chemoembolization in the treatment of hepatocellular carcinoma
BY Zhong, ZC Jin, JJ Chen, HD Zhu… - Journal of Clinical and …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. According
to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial …
to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial …
Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies
CH Rim, HJ Kim, J Seong - Radiotherapy and Oncology, 2019 - Elsevier
Background and purpose Stereotactic body radiotherapy (SBRT) is an emerging ablative
modality for hepatocellular carcinoma (HCC). This study aimed to synthesize available …
modality for hepatocellular carcinoma (HCC). This study aimed to synthesize available …
[HTML][HTML] Transcatheter embolization therapy in liver cancer: an update of clinical evidences
Transarterial chemoembolization (TACE) is a form of intra-arterial catheter-based
chemotherapy that selectively delivers high doses of cytotoxic drug to the tumor bed …
chemotherapy that selectively delivers high doses of cytotoxic drug to the tumor bed …
[HTML][HTML] 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association - Korean Journal of Radiology, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …
Percutaneous ablation for hepatocellular carcinoma: comparison of various ablation techniques and surgery
S Shiina, K Sato, R Tateishi, M Shimizu… - Canadian Journal of …, 2018 - Wiley Online Library
Image‐guided percutaneous ablation is considered best in the treatment of early‐stage
hepatocellular carcinoma (HCC). Ablation is potentially curative, minimally invasive, and …
hepatocellular carcinoma (HCC). Ablation is potentially curative, minimally invasive, and …
2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
Propensity score matching: a conceptual review for radiology researchers
The propensity score is defined as the probability of each individual study subject being
assigned to a group of interest for comparison purposes. Propensity score adjustment is a …
assigned to a group of interest for comparison purposes. Propensity score adjustment is a …
Microwave ablation in primary and secondary liver tumours: technical and clinical approaches
MF Meloni, J Chiang, PF Laeseke… - International journal …, 2017 - Taylor & Francis
Thermal ablation is increasingly being utilised in the treatment of primary and metastatic
liver tumours, both as curative therapy and as a bridge to transplantation. Recent advances …
liver tumours, both as curative therapy and as a bridge to transplantation. Recent advances …